These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33871581)

  • 1. Hydroxychloroquine-related hyperpigmentation.
    Muller R; Jarrot PA; Kaplanski G
    Rheumatology (Oxford); 2022 Feb; 61(2):873. PubMed ID: 33871581
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine-induced hyperpigmentation.
    Tracy CL; Blakey B; Parker G; Roebuck J
    J Clin Rheumatol; 2013 Aug; 19(5):292. PubMed ID: 23884186
    [No Abstract]   [Full Text] [Related]  

  • 3. Woman in grey: hydroxychloroquine-induced hyperpigmentation.
    Ivo R; Lopes CA; Reis R
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567137
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxycholoroquine-induced hyperpigmentation.
    Mir A; Boyd KP; Meehan SA; McLellan B
    Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine-induced hyperpigmentation of the skin.
    Sawalha AH
    J Rheumatol; 2015 Jan; 42(1):135-6. PubMed ID: 25554808
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperpigmentation of the skin due to hydroxychloroquine.
    Rood MJ; Vermeer MH; Huizinga TW
    Scand J Rheumatol; 2008; 37(2):158. PubMed ID: 18415776
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.
    Jallouli M; Francès C; Piette JC; Huong du LT; Moguelet P; Factor C; Zahr N; Miyara M; Saadoun D; Mathian A; Haroche J; De Gennes C; Leroux G; Chapelon C; Wechsler B; Cacoub P; Amoura Z; Costedoat-Chalumeau N;
    JAMA Dermatol; 2013 Aug; 149(8):935-40. PubMed ID: 23824340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S; Setterfield J; Black MM
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxychloroquine-induced hyperpigmentation.
    Kasper RS; Flueckiger B; Gobbi S; Lautenschlager S; Borelli S
    J Dtsch Dermatol Ges; 2014 Feb; 12(2):158-61. PubMed ID: 24494645
    [No Abstract]   [Full Text] [Related]  

  • 10. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
    Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
    Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine-induced pruritus.
    Holme SA; Holmes SC
    Acta Derm Venereol; 1999 Jul; 79(4):333. PubMed ID: 10430003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Skin pigmentation in a patient with systemic lupus erythematosus].
    Jallouli M; Leroux G; Halabi-Tawil M; Morel N; Francès C; Piette JC; Amoura Z; Costedoat-Chalumeau N
    Rev Med Interne; 2010 Aug; 31(8):566-7. PubMed ID: 20430486
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.
    Zhang S; Liu X; Cai L; Zhang J; Zhou C
    Lupus; 2019 Jan; 28(1):129-132. PubMed ID: 30428763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine Ocular Toxicity: Lessons Learned.
    Rabin JC; Ramirez K
    J Rheumatol; 2019 Dec; 46(12):1640-1641. PubMed ID: 31787594
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.
    Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z
    Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Young patient diagnosed with hydroxychloroquine intoxication].
    Gallego Muñoz C; Olmos Gutiérrez L; Guerrero Navarro N; Parra Alonso E
    Farm Hosp; 2017 May; 41(3):431-432. PubMed ID: 28478759
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxychloroquine-related skin discoloration.
    Coulombe J; Boccara O
    CMAJ; 2017 Feb; 189(5):E212. PubMed ID: 26903361
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of hydroxychloroquine in Japan.
    Kishimoto M; Deshpande GA; Yokogawa N; Buyon JP; Okada M
    J Rheumatol; 2012 Jun; 39(6):1296. PubMed ID: 22661421
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxychloroquine myopathy.
    Richards AJ
    J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine-induced hyperpigmentation: the staining pattern.
    Puri PK; Lountzis NI; Tyler W; Ferringer T
    J Cutan Pathol; 2008 Dec; 35(12):1134-7. PubMed ID: 18727667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.